Tula, Tula, Russian Federation
Tula, Tula, Russian Federation
UDC 61
Dyslipidemia is the main cause of a number of cardiovascular diseases, which are a serious problem for modern healthcare. The classes of drugs used for modern therapy of dyslipidemia (statins, fibrates, bile acid sequestrants, omega-3 polyunsaturated fatty acids) are characterized, and the features of their pharmacological action are considered. Information is provided on red rice extract derivatives as alternative remedies for correcting dyslipidemia in certain patient groups.
: dyslipidemia, new treatment methods, cardiovascular diseases, statins, fibrates, omega-3 fatty acids, bile acid sequestrants, red rice extract
1. Klinicheskie rekomendacii Narusheniya lipidnogo obmena/ Ezhov M. V.,Kuharchuk V. V., Sergienko I. V.[i dr.]; Obscherossiyskaya obschestvennaya organizaciya «Rossiyskoe kardiologicheskoe obschestvo». – Tekst: elektronnyy // Klinicheskie rekomendacii: [sayt]-2023- S.2-6.URL: https://cr.minzdrav.gov.ru/view-cr/752_1 (data obrascheniya: 09.11.2025).
2. Sivkov. A. S. Gipolipedemicheskie sredstva// Klinicheskaya farmakologiya 2006 №3. S. 478-480.
3. Tenenbaum, A., Fisman, E.Z. Fibraty yavlyayutsya vazhnoy chast'yu sovremennogo antidislipidemicheskogo arsenala: vnimanie k aterogennoy dislipidemii i snizheniyu ostatochnogo riska. Kardiovask Diabetol 11, 125 (2012). https://doi.org/10.1186/1475-2840-11-125
4. Susekov A. V. Fenofibrat pri lechenii bol'nyh s gipertrigliceridemiey i aterosklerozom. Novye dannye // Lechebnoe delo. 2020. №1. URL: https://cyberleninka.ru/article/n/fenofibrat-pri-lechenii-bolnyh-s-gipertriglitseridemiyami-i-aterosklerozom-novye-dannye (data obrascheniya: 09.11.2025).
5. Meduniver. Sekvestranty zhelchnyh kislot pri ateroskleroze. Pobochnye effekty sekvestrantov zhelchnyh kislot. https://meduniver.com/Medical/cardiologia/238.html MedUniver
6. Dzhanashiya P.H., Nazarenko V.A., Nikolenko S.A. Dislipoproteidemii: klinika, diagnostika, lechenie// Uchebnoe posobie. Rossiyskiy gosudarstvennyy medicinskiy universitet. Moskva, 2000. S. 25-28.
7. Aronov D.M., Lupanov V.P. Primenenie omega-3-polinenasyschennyh zhirnyh kislot pri koronarnoy bolezni serdca, ateroskleroze i dislipoproteidemii// Farmateka 2012 №14(247) S. 2-4.
8. Mal' G. S., Lazurina L. P., Oplimah K. S. Korrekciya lipidnogo profilya u bol'nyh IBS na fone farmakoterapii omakorom// Sciences of Europe. 2020. №55-1 (55). S. 6-7.
9. Torshin I.Yu., Gromova O.A. Al'ternativnye podhody k korrekcii giperholesterinemii: effekty standartizirovannyh ekstraktov krasnogo risa i ego sinergistov// Lechebnoe delo. 2021. №1. S. 89-97
10. Gromova O. A., Torshin I. Yu. Hemoreaktomnyy analiz prirodnyh i sinteticheskih statinov ukazyvaet na bolee blagopriyatnyy profil' bezopasnosti monakolina K// Eksperimental'naya i klinicheskaya gastroenterologiya. 2022; 199(3): 74–85. DOI:https://doi.org/10.31146/1682-8658-ecg-199-3-74-85
